DR. JOSEPH ROCCO PISEGNA, MD
Osteopathic Medicine at 120, Los Angeles, CA
License number
California G72435
Category
Osteopathic Medicine
Type
Gastroenterology
Address
Address
2
200 120Th St, Los Angeles, CA 90095
834 26Th St, Santa Monica, CA 90403
834 26Th St, Santa Monica, CA 90403
Phone
(310) 794-9718
(310) 268-3578
(310) 268-4096 (Fax)
(310) 268-3578
(310) 268-4096 (Fax)
Personal information
See more information about JOSEPH ROCCO PISEGNA at radaris.comName
Address
Phone
834 26Th St, Santa Monica, CA 90403
834 26Th St, Santa Monica, CA 90403
10853 Weyburn Ave, Los Angeles, CA 90024
3002 Sepulveda Blvd, Los Angeles, CA 90034
200 Ucla Medical Plz, West Los Angeles, CA 90025
Professional information
Dr. Joseph R Pisegna, Los Angeles CA - MD (Doctor of Medicine)
Specialties:
Gastroenterology
Address:
11301 Wilshire Blvd SUITE 115, Los Angeles 90073
(310) 478-3711 (Phone), (310) 268-4096 (Fax)
PISEGNA, JOSEPH R MD
2251 Wigwam Pkwy SUITE 1811, Henderson 89074
(233) 896-0338 (Phone)
10853 Weyburn Ave, Los Angeles 90024
VETERANS AFFAIRS MEDICAL CTR
11301 Wilshire Blvd, Los Angeles 90073
(310) 478-3711 (Phone), (310) 312-0572 (Fax)
PISEGNA, JOSEPH R MD
834 26Th St, Santa Monica 90403
(310) 478-3711 (Phone), (310) 268-4245 (Fax)
(310) 478-3711 (Phone), (310) 268-4096 (Fax)
PISEGNA, JOSEPH R MD
2251 Wigwam Pkwy SUITE 1811, Henderson 89074
(233) 896-0338 (Phone)
10853 Weyburn Ave, Los Angeles 90024
VETERANS AFFAIRS MEDICAL CTR
11301 Wilshire Blvd, Los Angeles 90073
(310) 478-3711 (Phone), (310) 312-0572 (Fax)
PISEGNA, JOSEPH R MD
834 26Th St, Santa Monica 90403
(310) 478-3711 (Phone), (310) 268-4245 (Fax)
Certifications:
Gastroenterology, 1991, Internal Medicine, 1989
Awards:
Healthgrades Honor Roll
Languages:
English, Italian
Hospitals:
11301 Wilshire Blvd SUITE 115, Los Angeles 90073
10853 Weyburn Ave, Los Angeles 90024
PISEGNA, JOSEPH R MD
2251 Wigwam Pkwy SUITE 1811, Henderson 89074
VETERANS AFFAIRS MEDICAL CTR
11301 Wilshire Blvd, Los Angeles 90073
PISEGNA, JOSEPH R MD
834 26Th St, Santa Monica 90403
Ronald Reagan UCLA Medical Center
757 Westwood Plz, Los Angeles 90095
UCLA Medical Center, Santa Monica
1250 16Th St, Santa Monica 90404
10853 Weyburn Ave, Los Angeles 90024
PISEGNA, JOSEPH R MD
2251 Wigwam Pkwy SUITE 1811, Henderson 89074
VETERANS AFFAIRS MEDICAL CTR
11301 Wilshire Blvd, Los Angeles 90073
PISEGNA, JOSEPH R MD
834 26Th St, Santa Monica 90403
Ronald Reagan UCLA Medical Center
757 Westwood Plz, Los Angeles 90095
UCLA Medical Center, Santa Monica
1250 16Th St, Santa Monica 90404
Education:
Medical School
University of Miami / School of Medicine
Graduated: 1986
U Miami/Jackson Meml Hosp
Georgetown U/Nih
University of Miami / School of Medicine
Graduated: 1986
U Miami/Jackson Meml Hosp
Georgetown U/Nih
Joseph Rocco Pisegna, Los Angeles CA
Specialties:
Gastroenterologist
Address:
11301 Wilshire Blvd, Los Angeles, CA 90073
834 26Th St, Santa Monica, CA 90403
834 26Th St, Santa Monica, CA 90403
Education:
University of Miami, Miller School of Medicine - Doctor of Medicine
Georgetown University Hospital - Fellowship - Gastroenterology (Internal Medicine)
Jackson Memorial Hospital - Residency - Internal Medicine
Georgetown University Hospital - Fellowship - Gastroenterology (Internal Medicine)
Jackson Memorial Hospital - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine
Joseph Rocco Pisegna, Los Angeles CA
Specialties:
Internal Medicine, Gastroenterology
Work:
Va Greater Los Angeles Healthcare System
11301 Wilshire Blvd, Los Angeles, CA 90073
11301 Wilshire Blvd, Los Angeles, CA 90073
Education:
University of Miami(1986) Gastroenterology
Use Of Pentagastrin To Inhibit Gastric Acid Secretion Or As A Diuretic
US Patent:
2008004, Feb 21, 2008
Filed:
Jul 30, 2007
Appl. No.:
11/830651
Inventors:
Joseph Pisegna - Santa Monica CA, US
Stephen Wank - Potomac MD, US
Stephen Wank - Potomac MD, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA - Oakland CA
International Classification:
A61K 38/16, A61K 38/08, A61P 1/00
US Classification:
514017000, 514002000
Abstract:
This invention pertains to the discovery that pentagastrin, when administered in conjunction with a proton pump inhibitor (PPI) is synergistic with the PPI and significantly increases the efficacy of the PPI in reducing/mitigating excess gastric acid secretion.
Cloning And Characterization Of Calcitonin Gene Related Peptide Receptors
US Patent:
2004011, Jun 10, 2004
Filed:
May 16, 2003
Appl. No.:
10/440479
Inventors:
Joseph Pisegna - Santa Monica CA, US
Stephen Wank - Potomac MD, US
Stephen Wank - Potomac MD, US
Assignee:
The Regents of the University of California
International Classification:
C12Q001/68, C07H021/04, C07K014/705
US Classification:
435/006000, 435/069100, 435/320100, 435/325000, 530/350000, 536/023500
Abstract:
This invention provides CGRP receptors (including both amino acid and nucleic acid sequences). Compositions which include these polypeptides, proteins, nucleic acids, recombinant cells, transgenic animals, and antibodies to the receptors are also provided.
Use Of Pentagastrin To Inhibit Gastric Acid Secretion Or As A Diuretic
US Patent:
7365047, Apr 29, 2008
Filed:
Sep 27, 2000
Appl. No.:
09/671764
Inventors:
Joseph R. Pisegna - Los Angeles CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 38/00, A61K 49/00
US Classification:
514 2, 514 13, 514 17, 514199, 514256, 514338, 514361, 530300, 530326, 530330, 424 91
Abstract:
This invention pertains to the discovery that pentagastrin, when administered in conjunction with a proton pump inhibitor (PPI) is synergistic with the PPI and significantly increases the efficacy of the PPI in reducing/mitigating excess gastric acid secretion.
Use Of Pentagastrin To Inhibit Gastric Acid Secretion Or As A Diuretic
US Patent:
7807623, Oct 5, 2010
Filed:
Dec 8, 2006
Appl. No.:
11/608667
Inventors:
Joseph R. Pisegna - Santa Monica CA, US
Stephen Wank - Potomac MD, US
Stephen Wank - Potomac MD, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 38/00, A61K 49/00
US Classification:
514 2, 514 13, 514 17, 514199, 514256, 514338, 514361, 530300, 530326, 530330, 424 91
Abstract:
This invention pertains to the discovery administration of a CCK receptor agonist can increase urinary sodium excretion and/or free water excretion in a mammal. CCK receptor agonist can thereby be used in the treatment of conditions such high blood pressure, fluid retention associated with heart failure, fluid retention associated with acute or chronic kidney failure, fluid retention associated with cirrhosis, fluid retention associated with liver failure, calcium kidney stones, nephrogenic diabetes insipidus, and renal tubular acidosis.
Joseph Pisegna
Location:
Greater Los Angeles Area
Industry:
Pharmaceuticals